235 related articles for article (PubMed ID: 36093876)
41. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
42. Liquid Biopsy: From Basic Research to Clinical Practice.
Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
[TBL] [Abstract][Full Text] [Related]
43. Potential of circulating biomarkers in liquid biopsy diagnostics.
Yeo JC; Lim CT
Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
[No Abstract] [Full Text] [Related]
44. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
[TBL] [Abstract][Full Text] [Related]
45. Advances in liquid biopsy-based markers in NSCLC.
Ren XD; Su N; Sun XG; Li WM; Li J; Li BW; Li RX; Lv J; Xu QY; Kong WL; Huang Q
Adv Clin Chem; 2023; 114():109-150. PubMed ID: 37268331
[TBL] [Abstract][Full Text] [Related]
46. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.
Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP
Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231
[TBL] [Abstract][Full Text] [Related]
47. Liquid Biopsy in Gliomas- A Review.
Ray A
Neurol India; 2020; 68(6):1295-1300. PubMed ID: 33342856
[TBL] [Abstract][Full Text] [Related]
48. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
Geeurickx E; Hendrix A
Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
[TBL] [Abstract][Full Text] [Related]
49. Role of liquid biopsies in colorectal cancer.
Wills B; Gorse E; Lee V
Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
[TBL] [Abstract][Full Text] [Related]
50. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
51. Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
Birkó Z; Nagy B; Klekner Á; Virga J
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053907
[No Abstract] [Full Text] [Related]
52. Liquid biopsy in germ cell tumors: biology and clinical management.
Chovanec M; Kalavska K; Mego M; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083
[No Abstract] [Full Text] [Related]
53. Recent advances in the use of liquid biopsy to fight central nervous system tumors.
Pilotto Heming C; Niemeyer Filho P; Moura-Neto V; Aran V
Cancer Treat Res Commun; 2023; 35():100709. PubMed ID: 37088042
[TBL] [Abstract][Full Text] [Related]
54. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
Giannopoulou L; Kasimir-Bauer S; Lianidou ES
Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
[TBL] [Abstract][Full Text] [Related]
55. Liquid biopsies for hepatocellular carcinoma.
Su YH; Kim AK; Jain S
Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
[TBL] [Abstract][Full Text] [Related]
56. Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
Le Rhun E; Seoane J; Salzet M; Soffietti R; Weller M
Cancer Lett; 2020 Jun; 480():24-28. PubMed ID: 32229189
[TBL] [Abstract][Full Text] [Related]
57. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.
Lodewijk I; Dueñas M; Rubio C; Munera-Maravilla E; Segovia C; Bernardini A; Teijeira A; Paramio JM; Suárez-Cabrera C
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149597
[TBL] [Abstract][Full Text] [Related]
58. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919
[TBL] [Abstract][Full Text] [Related]
59. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
60. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.
Karimi F; Azadbakht O; Veisi A; Sabaghan M; Owjfard M; Kharazinejad E; Dinarvand N
Med Oncol; 2023 Aug; 40(9):265. PubMed ID: 37561363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
